Rapid Therapeutic Science Laboratories, Inc.
RTSL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.53K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3,533.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.01 |
| Beta | -2 |
| Outstanding Shares | 0 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0.02 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Rapid Therapeutic Science Laboratories, Inc.
3 employees
CEO: Donal R. Schmidt Jr.
Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various co...